DealShot

DealShot: Harvest Investments Leads $14.6M Series B Round In Chinese Cancer Diagnosis Firm Viroad Biotech

Follow Us:
LinkedIn
Twitter
YouTube
Facebook
Weibo
InventisBio's product pipeline includes small molecule drug candidates for targeted therapies in lung cancer and breast cancer.

China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.

Here you can find out where Chinese investors have been investing their money each workday.

CompanyRoundLead InvestorParticipantsSectorHeadquarters
Viroad BiotechnologySeries BHarvest InvestmentsHealthcareShijiazhuang
Zhangyu TechnologySeed RoundFundamental LabsBlockchainShanghai
Juyun InformationAngel RoundA&Z CapitalAdvertising & MarketingShanghai
LaiOfferSeries ANew Oriental Education and Technology GroupEducation
eyou800.comSeries AGalaxy CapitalLogisticsShanghai
Shengmei BiotechSeries AKangcheng InvestmentZhuhai Venture CapitalHealthcareZhuhai
Going-LinkSeries AJD.com, Zhongmi CapitalEnterprise servicesShanghai
NovoShinePre-AChina Growth CapitalTHG VenturesSmart HardwareWeifang
 


Related News








Leave a Reply

Your email address will not be published. Required fields are marked *